Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

The Oncologist(2022)10.1093/oncolo/oyac162Source: DataRank Database

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience is a research paper published in The Oncologist (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.45)OA: goldTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Jane E. Rogers ORCID,Hyunsoo Hwang ORCID,Wei Qiao ORCID,Lianchun Xiao ORCID,Arvind Dasari ORCID

Live enrichment

PubMed:35946836 PMC:PMC9632313 OpenAlex:https://openalex.org/W4297830885

National Institutes of Health

Grant: NCI P30 CA016672

NCI NIH HHS

Grant: P30 CA016672

National Institutes of Health

Grant: 3P30CA016672-41S4

Cancer Center Support (CORE) Grant

FWCI

2.45

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc

journalhttps://academic.oup.com/oncolo/article-pdf/27/11/952/46832169/oyac162.pdf

publisherhttps://academic.oup.com/oncolo/article-pdf/27/11/952/46832169/oyac162.pdf

journalhttps://doi.org/10.1093/oncolo/oyac162

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35946836

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9632313

Fields of Study

Genetic factors in colorectal cancerCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis0301 basic medicine0303 health sciences03 medical and health sciencesHumansDNA Mismatch RepairImmune Checkpoint InhibitorsProspective StudiesAnti-Bacterial AgentsColorectal NeoplasmsMicrosatellite InstabilityColonic Neoplasms

MeSH Terms

Immune Checkpoint InhibitorsAnti-Bacterial AgentsColonic NeoplasmsHumansProspective StudiesColorectal NeoplasmsMicrosatellite InstabilityDNA Mismatch Repair

Keywords

PembrolizumabNivolumabMedicineMicrosatellite instabilityOncologyColorectal cancerInternal medicineImmune checkpointCancerClinical endpointCohortConcomitantBlockadeImmunotherapyClinical trialAntibioticsColon cancerMicrobiomeMedical SciencesBioinformatics610DNA Mismatch RepairBiomedical InformaticsAnti-Bacterial Agents616Gastrointestinal CancerColonic NeoplasmsMedical SpecialtiesMedicine and Health SciencesHumansProspective StudiesColorectal NeoplasmsImmune Checkpoint Inhibitors

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: No poverty

Antibiotic Exposure Does Not Impact Immune Checkpoint Blockade Response in MSI-H/dMMR Metastatic Colorectal Cancer: A Single-Center Experience

FAIR Checklist

Authors (16)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)